Global Gene Therapy on Neurological Diseases Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Gene Therapy on Neurological Diseases market size was valued at USD 4472.8 million in 2023 and is forecast to a readjusted size of USD 12130 million by 2030 with a CAGR of 15.3% during review period.

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

The Drug Based on Gene Therapy market is primarily driven by the revolutionary potential of gene therapy to address genetic disorders at their root cause, offering a new paradigm for treating previously incurable conditions. Gene therapy involves introducing genetic material into a patient's cells to correct or replace faulty genes, aiming to restore normal cellular function. The increasing understanding of the genetic basis of diseases, coupled with advancements in gene delivery methods and genome editing techniques, contributes to market growth. Moreover, the demonstrated benefits of gene therapy in providing targeted and long-lasting treatments, overcoming limitations of traditional pharmacological approaches, and offering hope to patients with rare genetic disorders further propel adoption. However, challenges include optimizing gene delivery efficiency, addressing potential immune responses, and ensuring the long-term safety and durability of gene-based treatments. Navigating regulatory pathways, conducting rigorous clinical trials, and addressing ethical considerations are ongoing concerns. The market's success relies on continuous research in genetic medicine, collaborations between biotechnology companies and research institutions, and comprehensive education on the benefits and potential challenges of using gene therapy-based drugs while addressing the evolving challenges associated with precision medicine and personalized treatments.

The Global Info Research report includes an overview of the development of the Gene Therapy on Neurological Diseases industry chain, the market status of Hospital (Viral Gene Therapy, Non-viral Gene Therapy), Clinic (Viral Gene Therapy, Non-viral Gene Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gene Therapy on Neurological Diseases.

Regionally, the report analyzes the Gene Therapy on Neurological Diseases markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gene Therapy on Neurological Diseases market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Gene Therapy on Neurological Diseases market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gene Therapy on Neurological Diseases industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Viral Gene Therapy, Non-viral Gene Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gene Therapy on Neurological Diseases market.

Regional Analysis: The report involves examining the Gene Therapy on Neurological Diseases market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene Therapy on Neurological Diseases market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Gene Therapy on Neurological Diseases:
Company Analysis: Report covers individual Gene Therapy on Neurological Diseases players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene Therapy on Neurological Diseases This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).

Technology Analysis: Report covers specific technologies relevant to Gene Therapy on Neurological Diseases. It assesses the current state, advancements, and potential future developments in Gene Therapy on Neurological Diseases areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gene Therapy on Neurological Diseases market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Gene Therapy on Neurological Diseases market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Viral Gene Therapy
    Non-viral Gene Therapy

Market segment by Application
    Hospital
    Clinic
    Other

Market segment by players, this report covers
    Biogen
    Novartis
    Sarepta Therapeutics

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy on Neurological Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy on Neurological Diseases, with revenue, gross margin and global market share of Gene Therapy on Neurological Diseases from 2019 to 2024.
Chapter 3, the Gene Therapy on Neurological Diseases competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gene Therapy on Neurological Diseases market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy on Neurological Diseases.
Chapter 13, to describe Gene Therapy on Neurological Diseases research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gene Therapy on Neurological Diseases
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Gene Therapy on Neurological Diseases by Type
        1.3.1 Overview: Global Gene Therapy on Neurological Diseases Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Gene Therapy on Neurological Diseases Consumption Value Market Share by Type in 2023
        1.3.3 Viral Gene Therapy
        1.3.4 Non-viral Gene Therapy
    1.4 Global Gene Therapy on Neurological Diseases Market by Application
        1.4.1 Overview: Global Gene Therapy on Neurological Diseases Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Other
    1.5 Global Gene Therapy on Neurological Diseases Market Size & Forecast
    1.6 Global Gene Therapy on Neurological Diseases Market Size and Forecast by Region
        1.6.1 Global Gene Therapy on Neurological Diseases Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Gene Therapy on Neurological Diseases Market Size by Region, (2019-2030)
        1.6.3 North America Gene Therapy on Neurological Diseases Market Size and Prospect (2019-2030)
        1.6.4 Europe Gene Therapy on Neurological Diseases Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Gene Therapy on Neurological Diseases Market Size and Prospect (2019-2030)
        1.6.6 South America Gene Therapy on Neurological Diseases Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Gene Therapy on Neurological Diseases Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Biogen
        2.1.1 Biogen Details
        2.1.2 Biogen Major Business
        2.1.3 Biogen Gene Therapy on Neurological Diseases Product and Solutions
        2.1.4 Biogen Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Biogen Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Gene Therapy on Neurological Diseases Product and Solutions
        2.2.4 Novartis Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 Sarepta Therapeutics
        2.3.1 Sarepta Therapeutics Details
        2.3.2 Sarepta Therapeutics Major Business
        2.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Product and Solutions
        2.3.4 Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Sarepta Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gene Therapy on Neurological Diseases Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Gene Therapy on Neurological Diseases by Company Revenue
        3.2.2 Top 3 Gene Therapy on Neurological Diseases Players Market Share in 2023
        3.2.3 Top 6 Gene Therapy on Neurological Diseases Players Market Share in 2023
    3.3 Gene Therapy on Neurological Diseases Market: Overall Company Footprint Analysis
        3.3.1 Gene Therapy on Neurological Diseases Market: Region Footprint
        3.3.2 Gene Therapy on Neurological Diseases Market: Company Product Type Footprint
        3.3.3 Gene Therapy on Neurological Diseases Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Gene Therapy on Neurological Diseases Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Gene Therapy on Neurological Diseases Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Gene Therapy on Neurological Diseases Consumption Value Market Share by Application (2019-2024)
    5.2 Global Gene Therapy on Neurological Diseases Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Gene Therapy on Neurological Diseases Consumption Value by Type (2019-2030)
    6.2 North America Gene Therapy on Neurological Diseases Consumption Value by Application (2019-2030)
    6.3 North America Gene Therapy on Neurological Diseases Market Size by Country
        6.3.1 North America Gene Therapy on Neurological Diseases Consumption Value by Country (2019-2030)
        6.3.2 United States Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        6.3.3 Canada Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        6.3.4 Mexico Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Gene Therapy on Neurological Diseases Consumption Value by Type (2019-2030)
    7.2 Europe Gene Therapy on Neurological Diseases Consumption Value by Application (2019-2030)
    7.3 Europe Gene Therapy on Neurological Diseases Market Size by Country
        7.3.1 Europe Gene Therapy on Neurological Diseases Consumption Value by Country (2019-2030)
        7.3.2 Germany Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        7.3.3 France Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        7.3.5 Russia Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        7.3.6 Italy Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region
        8.3.1 Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Region (2019-2030)
        8.3.2 China Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        8.3.3 Japan Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        8.3.4 South Korea Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        8.3.5 India Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        8.3.7 Australia Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Gene Therapy on Neurological Diseases Consumption Value by Type (2019-2030)
    9.2 South America Gene Therapy on Neurological Diseases Consumption Value by Application (2019-2030)
    9.3 South America Gene Therapy on Neurological Diseases Market Size by Country
        9.3.1 South America Gene Therapy on Neurological Diseases Consumption Value by Country (2019-2030)
        9.3.2 Brazil Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        9.3.3 Argentina Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country
        10.3.1 Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Country (2019-2030)
        10.3.2 Turkey Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)
        10.3.4 UAE Gene Therapy on Neurological Diseases Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Gene Therapy on Neurological Diseases Market Drivers
    11.2 Gene Therapy on Neurological Diseases Market Restraints
    11.3 Gene Therapy on Neurological Diseases Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Gene Therapy on Neurological Diseases Industry Chain
    12.2 Gene Therapy on Neurological Diseases Upstream Analysis
    12.3 Gene Therapy on Neurological Diseases Midstream Analysis
    12.4 Gene Therapy on Neurological Diseases Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gene Therapy on Neurological Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Gene Therapy on Neurological Diseases Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Gene Therapy on Neurological Diseases Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Gene Therapy on Neurological Diseases Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Biogen Company Information, Head Office, and Major Competitors
    Table 6. Biogen Major Business
    Table 7. Biogen Gene Therapy on Neurological Diseases Product and Solutions
    Table 8. Biogen Gene Therapy on Neurological Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Biogen Recent Developments and Future Plans
    Table 10. Novartis Company Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Gene Therapy on Neurological Diseases Product and Solutions
    Table 13. Novartis Gene Therapy on Neurological Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Novartis Recent Developments and Future Plans
    Table 15. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
    Table 16. Sarepta Therapeutics Major Business
    Table 17. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product and Solutions
    Table 18. Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Sarepta Therapeutics Recent Developments and Future Plans
    Table 20. Global Gene Therapy on Neurological Diseases Revenue (USD Million) by Players (2019-2024)
    Table 21. Global Gene Therapy on Neurological Diseases Revenue Share by Players (2019-2024)
    Table 22. Breakdown of Gene Therapy on Neurological Diseases by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 23. Market Position of Players in Gene Therapy on Neurological Diseases, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 24. Head Office of Key Gene Therapy on Neurological Diseases Players
    Table 25. Gene Therapy on Neurological Diseases Market: Company Product Type Footprint
    Table 26. Gene Therapy on Neurological Diseases Market: Company Product Application Footprint
    Table 27. Gene Therapy on Neurological Diseases New Market Entrants and Barriers to Market Entry
    Table 28. Gene Therapy on Neurological Diseases Mergers, Acquisition, Agreements, and Collaborations
    Table 29. Global Gene Therapy on Neurological Diseases Consumption Value (USD Million) by Type (2019-2024)
    Table 30. Global Gene Therapy on Neurological Diseases Consumption Value Share by Type (2019-2024)
    Table 31. Global Gene Therapy on Neurological Diseases Consumption Value Forecast by Type (2025-2030)
    Table 32. Global Gene Therapy on Neurological Diseases Consumption Value by Application (2019-2024)
    Table 33. Global Gene Therapy on Neurological Diseases Consumption Value Forecast by Application (2025-2030)
    Table 34. North America Gene Therapy on Neurological Diseases Consumption Value by Type (2019-2024) & (USD Million)
    Table 35. North America Gene Therapy on Neurological Diseases Consumption Value by Type (2025-2030) & (USD Million)
    Table 36. North America Gene Therapy on Neurological Diseases Consumption Value by Application (2019-2024) & (USD Million)
    Table 37. North America Gene Therapy on Neurological Diseases Consumption Value by Application (2025-2030) & (USD Million)
    Table 38. North America Gene Therapy on Neurological Diseases Consumption Value by Country (2019-2024) & (USD Million)
    Table 39. North America Gene Therapy on Neurological Diseases Consumption Value by Country (2025-2030) & (USD Million)
    Table 40. Europe Gene Therapy on Neurological Diseases Consumption Value by Type (2019-2024) & (USD Million)
    Table 41. Europe Gene Therapy on Neurological Diseases Consumption Value by Type (2025-2030) & (USD Million)
    Table 42. Europe Gene Therapy on Neurological Diseases Consumption Value by Application (2019-2024) & (USD Million)
    Table 43. Europe Gene Therapy on Neurological Diseases Consumption Value by Application (2025-2030) & (USD Million)
    Table 44. Europe Gene Therapy on Neurological Diseases Consumption Value by Country (2019-2024) & (USD Million)
    Table 45. Europe Gene Therapy on Neurological Diseases Consumption Value by Country (2025-2030) & (USD Million)
    Table 46. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Type (2019-2024) & (USD Million)
    Table 47. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Type (2025-2030) & (USD Million)
    Table 48. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Application (2019-2024) & (USD Million)
    Table 49. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Application (2025-2030) & (USD Million)
    Table 50. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Region (2019-2024) & (USD Million)
    Table 51. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Region (2025-2030) & (USD Million)
    Table 52. South America Gene Therapy on Neurological Diseases Consumption Value by Type (2019-2024) & (USD Million)
    Table 53. South America Gene Therapy on Neurological Diseases Consumption Value by Type (2025-2030) & (USD Million)
    Table 54. South America Gene Therapy on Neurological Diseases Consumption Value by Application (2019-2024) & (USD Million)
    Table 55. South America Gene Therapy on Neurological Diseases Consumption Value by Application (2025-2030) & (USD Million)
    Table 56. South America Gene Therapy on Neurological Diseases Consumption Value by Country (2019-2024) & (USD Million)
    Table 57. South America Gene Therapy on Neurological Diseases Consumption Value by Country (2025-2030) & (USD Million)
    Table 58. Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Type (2019-2024) & (USD Million)
    Table 59. Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Type (2025-2030) & (USD Million)
    Table 60. Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Application (2019-2024) & (USD Million)
    Table 61. Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Application (2025-2030) & (USD Million)
    Table 62. Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Country (2019-2024) & (USD Million)
    Table 63. Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Country (2025-2030) & (USD Million)
    Table 64. Gene Therapy on Neurological Diseases Raw Material
    Table 65. Key Suppliers of Gene Therapy on Neurological Diseases Raw Materials
List of Figures
    Figure 1. Gene Therapy on Neurological Diseases Picture
    Figure 2. Global Gene Therapy on Neurological Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Gene Therapy on Neurological Diseases Consumption Value Market Share by Type in 2023
    Figure 4. Viral Gene Therapy
    Figure 5. Non-viral Gene Therapy
    Figure 6. Global Gene Therapy on Neurological Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Gene Therapy on Neurological Diseases Consumption Value Market Share by Application in 2023
    Figure 8. Hospital Picture
    Figure 9. Clinic Picture
    Figure 10. Other Picture
    Figure 11. Global Gene Therapy on Neurological Diseases Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Gene Therapy on Neurological Diseases Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Market Gene Therapy on Neurological Diseases Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 14. Global Gene Therapy on Neurological Diseases Consumption Value Market Share by Region (2019-2030)
    Figure 15. Global Gene Therapy on Neurological Diseases Consumption Value Market Share by Region in 2023
    Figure 16. North America Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 17. Europe Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 18. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 19. South America Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 20. Middle East and Africa Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 21. Global Gene Therapy on Neurological Diseases Revenue Share by Players in 2023
    Figure 22. Gene Therapy on Neurological Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 23. Global Top 3 Players Gene Therapy on Neurological Diseases Market Share in 2023
    Figure 24. Global Top 6 Players Gene Therapy on Neurological Diseases Market Share in 2023
    Figure 25. Global Gene Therapy on Neurological Diseases Consumption Value Share by Type (2019-2024)
    Figure 26. Global Gene Therapy on Neurological Diseases Market Share Forecast by Type (2025-2030)
    Figure 27. Global Gene Therapy on Neurological Diseases Consumption Value Share by Application (2019-2024)
    Figure 28. Global Gene Therapy on Neurological Diseases Market Share Forecast by Application (2025-2030)
    Figure 29. North America Gene Therapy on Neurological Diseases Consumption Value Market Share by Type (2019-2030)
    Figure 30. North America Gene Therapy on Neurological Diseases Consumption Value Market Share by Application (2019-2030)
    Figure 31. North America Gene Therapy on Neurological Diseases Consumption Value Market Share by Country (2019-2030)
    Figure 32. United States Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 33. Canada Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 34. Mexico Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 35. Europe Gene Therapy on Neurological Diseases Consumption Value Market Share by Type (2019-2030)
    Figure 36. Europe Gene Therapy on Neurological Diseases Consumption Value Market Share by Application (2019-2030)
    Figure 37. Europe Gene Therapy on Neurological Diseases Consumption Value Market Share by Country (2019-2030)
    Figure 38. Germany Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 39. France Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 40. United Kingdom Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 41. Russia Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 42. Italy Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 43. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value Market Share by Type (2019-2030)
    Figure 44. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value Market Share by Application (2019-2030)
    Figure 45. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value Market Share by Region (2019-2030)
    Figure 46. China Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 47. Japan Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 48. South Korea Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 49. India Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 50. Southeast Asia Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 51. Australia Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 52. South America Gene Therapy on Neurological Diseases Consumption Value Market Share by Type (2019-2030)
    Figure 53. South America Gene Therapy on Neurological Diseases Consumption Value Market Share by Application (2019-2030)
    Figure 54. South America Gene Therapy on Neurological Diseases Consumption Value Market Share by Country (2019-2030)
    Figure 55. Brazil Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 56. Argentina Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 57. Middle East and Africa Gene Therapy on Neurological Diseases Consumption Value Market Share by Type (2019-2030)
    Figure 58. Middle East and Africa Gene Therapy on Neurological Diseases Consumption Value Market Share by Application (2019-2030)
    Figure 59. Middle East and Africa Gene Therapy on Neurological Diseases Consumption Value Market Share by Country (2019-2030)
    Figure 60. Turkey Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 61. Saudi Arabia Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 62. UAE Gene Therapy on Neurological Diseases Consumption Value (2019-2030) & (USD Million)
    Figure 63. Gene Therapy on Neurological Diseases Market Drivers
    Figure 64. Gene Therapy on Neurological Diseases Market Restraints
    Figure 65. Gene Therapy on Neurological Diseases Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Gene Therapy on Neurological Diseases in 2023
    Figure 68. Manufacturing Process Analysis of Gene Therapy on Neurological Diseases
    Figure 69. Gene Therapy on Neurological Diseases Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Companies Mentioned

Biogen
Novartis
Sarepta Therapeutics